For: | Sacco E, Bientinesi R. Mirabegron, a novel, non-antimuscarinic drug for the overactive bladder: An up-to-dated review. World J Obstet Gynecol 2013; 2(4): 65-73 [DOI: 10.5317/wjog.v2.i4.65] |
---|---|
URL: | https://www.wjgnet.com/2218-6220/full/v2/i4/65.htm |
Number | Citing Articles |
1 |
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi, Enrico Finazzi Agrò. New treatments for neurogenic detrusor overactivity. Clinical Investigation 2015; 5(5): 519 doi: 10.4155/cli.15.12
|
2 |
Huan Guo, Jing Li, Delong Liu, Wanbin Zhang. The Synthesis of Chiral α‐Aryl α‐Hydroxy Carboxylic Acids via RuPHOX‐Ru Catalyzed Asymmetric Hydrogenation. Advanced Synthesis & Catalysis 2017; 359(20): 3665 doi: 10.1002/adsc.201700846
|
3 |
A. Alcántara Montero. Novedades en el tratamiento médico de la vejiga hiperactiva. SEMERGEN - Medicina de Familia 2016; 42(8): 557 doi: 10.1016/j.semerg.2015.10.006
|
4 |
Emilio Sacco, Riccardo Bientinesi, Daniele Tienforti, Marco Racioppi, Gaetano Gulino, Daniele D'Agostino, Matteo Vittori, Pierfrancesco Bassi. Discovery history and clinical development of mirabegron for the treatment of overactive bladder and urinary incontinence. Expert Opinion on Drug Discovery 2014; 9(4): 433 doi: 10.1517/17460441.2014.892923
|
5 |
Huanxian Chen, Maggie Pui Man Hoi, Simon Ming Yuen Lee. Medicinal plants and natural products for treating overactive bladder. Chinese Medicine 2024; 19(1) doi: 10.1186/s13020-024-00884-3
|
6 |
Qi-Long Zhang, Zhi-Yuan Zhuang, Qing-Dong Liu, Zhan-Ming Zhang, Fu-Xu Zhan, Geng-Xiu Zheng. Concise Synthesis of Key Intermediate of Mirabegron via a Mixed Anhydride Method. Organic Process Research & Development 2016; 20(11): 1993 doi: 10.1021/acs.oprd.6b00231
|
7 |
Saima Ejaz, Humaira Nadeem, Rehan Zafar Paracha, Sadia Sarwar, Sadaf Ejaz. Designing, synthesis and characterization of 2-aminothiazole-4-carboxylate Schiff bases; antimicrobial evaluation against multidrug resistant strains and molecular docking. BMC Chemistry 2019; 13(1) doi: 10.1186/s13065-019-0631-6
|